Cleared Traditional

K830204 - DAC-CEL DIAGNATAL HCG STANDARDS RD49

K830204 is the FDA 510(k) clearance for DAC-CEL DIAGNATAL HCG STANDARDS RD49 by Wellcome Diagnostics. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 29-day FDA review.

K830204 · Wellcome Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1983
Decision
29d
Days
Class 1
Risk

K830204 is an FDA 510(k) clearance for the DAC-CEL DIAGNATAL HCG STANDARDS RD49. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Wellcome Diagnostics (Mchenry, US). The FDA issued a Cleared decision on February 18, 1983 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Wellcome Diagnostics devices

Submission Details

510(k) Number K830204 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 20, 1983
Decision Date February 18, 1983
Days to Decision 29 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 88d · This submission: 29d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 372
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K830204.
CHEM TRAK LIQUID BILIRUBIN CONTROL
K833097 · Medical Analysis Systems, Inc. · Jan 1984
SPINAL FLUID TOTAL PROTEIN CONTROL
K831527 · Quantimetrix Corp. · Jul 1983
PHADEBAS HUMYLASE CONTROL(H)
K823421 · Pharmacia, Inc. · Apr 1983
BIO INTERFERENCE BLANKING MATERIAL
K823687 · American Monitor Corp. · Jan 1983
HUMAN PLASMA CONTROL FOR CEA-ROCHE
K822219 · Hoffmann-La Roche, Inc. · Dec 1982
PHADEBASE HUMYLASE CONTROL
K822938 · Pharmacia, Inc. · Nov 1982